Insider: Reumuth Mary CHIEF FINANCIAL OFFICER - Kala Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 28,906 | 0 | 28,906 |
| Value | $4,919.80 | $0.00 | $4,919.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/23/2025 | DDS | 967 | Direct | COM | $0.82 | $792.94 | 28,906 |
| 10/22/2025 | DDS | 32,230 | Direct | COM | $0.83 | $26,750.90 | 29,873 |
| 06/24/2025 | DDS | 3,631 | Direct | COM | $4.01 | $14,560.31 | 62,100 |
| 06/03/2025 | DDS | 2,850 | Direct | COM | $3.74 | $10,659.00 | 65,731 |
| 06/26/2024 | DDS | 4,163 | Direct | COM | $4.75 | $19,774.25 | 60,187 |
| 05/31/2024 | DDS | 1,786 | Direct | COM | $6.09 | $10,876.74 | 64,350 |
| 01/04/2023 | DDS | 60 | Direct | COM | $28.54 | $1,712.40 | 11,883 |
| 10/26/2022 | DDS | 194 | Direct | COM | $6.51 | $1,262.94 | 2,418 |
| 06/27/2022 | DDS | 2,613 | Direct | COM | $0.37 | $966.81 | 130,595 |
| 01/04/2022 | DDS | 2,850 | Direct | COM | $1.30 | $3,705.00 | 133,208 |
| 10/26/2021 | DDS | 9,449 | Direct | COM | $1.80 | $17,008.20 | 136,058 |
| 06/28/2021 | DDS | 2,452 | Direct | COM | $5.77 | $14,148.04 | 145,507 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research